A series editorial by Salvatore J Enna, PhD
Neuropsychopharmacology Reviews replaces the Generation of Progress,which consisted of five volumes published intermittently between 1968 and 2002. While the Generation of Progress served for decades as a major reference work, a single large volume is an increasingly difficult mechanism for promulgating new data given the pace of research, developments in information technology, and the time needed for authoring, editing, printing, and distributing such a massive work... read editorial in its entirety. View the first volume of NPP Reviews.
Volume One
Volume Two
Volume Three
Volume Four
Table of Contents
VOLUME 5
Editorial: NeurotherapeuticsGwenn S Smith, Xiaohua Li and P Jeffrey ConnReviews From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment Muscarinic and Nicotinic Acetylcholine Receptor Agonists and Allosteric Modulators for the Treatment of Schizophrenia Cognitive Training for Impaired Neural Systems in Neuropsychiatric Illness Review of Pharmacological Treatment in Mood Disorders and Future Directions for Drug Development Somatic Treatments for Mood Disorders Cognitive Mechanisms of Treatment in Depression Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior Novel Therapeutic Strategies for Alcohol and Drug Addiction: Focus on GABA, Ion Channels and Transcranial Magnetic Stimulation Therapeutic Strategies in Fragile X Syndrome: Dysregulated mGluR Signaling and Beyond Networking in Autism: Leveraging Genetic, Biomarker and Model System Findings in the Search for New Treatments Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa Epigenetic Treatments for Cognitive Impairments Alzheimer's Therapeutics: Translation of Preclinical Science to Clinical Drug DevelopmentCommentaries New Era for Novel CNS Drug Development Translating Discoveries into Medicine: Psychiatric Drug Development in 2011 NIA Commentary: Translational Issues in Alzheimer's Disease Drug Development Neuroscience Networking: Linking Discovery to Drugs
New Medications for Substance Use Disorders: Challenges and Opportunities The Role of Complementary, Alternative, and Integrative Medicine in Personalized Health CareHot Topics Grateful DREADDs: Engineered Receptors Reveal How Neural Circuits Regulate Behavior Dopamine D3 Receptor Function and Cocaine Exposure Chronic N-acetylcysteine after cocaine self-administration produces enduring reductions in drug-seeking Methamphetamine-Induced Oxidation of Proteins and Alterations in Protein Processing Placental Source for 5-HT that Tunes Fetal Brain Development Mainstreaming Mice Phospholipase D as a Therapeutic Target in Brain Disorders Transferrin Antibodies Into the Brain Endogenous Opioids as Physiological Antidepressants: Complementary Role of Delta Receptors and Dopamine Oxytocin as a Potential Therapeutic Target for Schizophrenia and Other Neuropsychiatric Conditions Dysregulation of mTOR Signaling in Neuropsychiatric Disorders: Therapeutic Implications Habenular Signaling in Nicotine Reinforcement Circuits, Cells, and Synapses: Toward a New Target for Deep Brain Stimulation in Depression Update on Corticotropin-Releasing Factor Pharmacotherapy for Psychiatric Disorders: A Revisionist View Update on Omega-3 Polyunsaturated Fatty Acids in Early-Stage Psychotic Disorders Beyond Antipsychotics: Pharmacologically-Augmented Cognitive Therapies (PACTs) for Schizophrenia From Father to Offspring: Paternal Transmission of Depressive-Like Behaviors
View the NPPR Nature website